| 4711 |
Centers for Disease Control and Prevention |
Html |
en |
Flu and People with Asthma |
Flu and People with Asthma - CDC |
| flu illness milder | 0.605655 |
| acute respiratory diseases | 0.544463 |
| Stay home | 0.474015 |
| Flu vaccines | 0.559236 |
| Pneumococcal vaccines | 0.476966 |
| flu vaccine | 0.558721 |
| lung disease | 0.49353 |
| lung airways | 0.51059 |
| trade name Relenza® | 0.473363 |
| important step | 0.479757 |
| allergy particles | 0.485387 |
| airway infections | 0.502451 |
| sensitive airways | 0.496187 |
| antiviral drug | 0.607376 |
| common medical conditions | 0.543537 |
| different antiviral drug | 0.570828 |
| chest tightness | 0.489686 |
| health departments | 0.47533 |
| common long-term diseases | 0.559157 |
| health conditions | 0.478928 |
| chronic inflammation | 0.499951 |
| asthma attacks | 0.923626 |
| early morning coughing | 0.564648 |
| influenza vaccine | 0.508235 |
|
| trade name Tamiflu® | 0.474002 |
| public schools | 0.477745 |
| flu hospitalizations | 0.565747 |
| Asthma Action Plan | 0.715854 |
| antiviral drugs | 0.556238 |
| antiviral drug treatment | 0.566425 |
| asthma | 0.930157 |
| flu viruses | 0.546587 |
| college health centers | 0.543546 |
| Influenza infection | 0.512599 |
| people | 0.531194 |
| medical care | 0.475999 |
| chemical irritants | 0.493795 |
| lung problems | 0.475053 |
| common medical condition | 0.545232 |
| influenza infections | 0.512655 |
| asthma medications | 0.688112 |
| FluView Interactive application | 0.545185 |
| regular doctor | 0.477146 |
| asthma symptoms | 0.68507 |
| air pollution | 0.485197 |
| trade name Rapivab® | 0.473915 |
| asthma experience symptoms | 0.763311 |
|
CLICK HERE |
| 9529 |
Centers for Disease Control and Prevention |
Html |
en |
Health Alert Network | Recurrent Nationwide Shortage of Tuberculin Skin Test Antigen Solutions: CDC Recommendations for Patient Care and Public Health Practice |
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC). |
| IGRA test materials | 0.651491 |
| PPD tuberculin product | 0.536671 |
| JHP Pharmaceuticals | 0.518979 |
| IGRAs entail services | 0.494798 |
| occupational health | 0.504126 |
| public health authorities | 0.498054 |
| TB contact investigations | 0.589908 |
| occupational health authorities | 0.490089 |
| IGRA products | 0.542366 |
| borderline results | 0.517588 |
| results | 0.519472 |
| Mycobacterium tuberculosis infection | 0.525671 |
| routine serial TSTs | 0.494246 |
| tuberculin skin tests | 0.560965 |
| public health rules | 0.497612 |
| Substitute IGRA blood | 0.665238 |
| public health officials | 0.524385 |
| interferon-γ release assay | 0.501042 |
| tuberculin antigen solutions | 0.533402 |
| United States Food | 0.510701 |
| TST | 0.562194 |
| M. tuberculosis infection | 0.520221 |
| cross-sectional controlled studies | 0.492998 |
| IGRA blood tests | 0.939586 |
|
| CDC Health Alert | 0.557048 |
| TB exposure | 0.506351 |
| United States | 0.623978 |
| similar results | 0.516541 |
| IGRA blood | 0.957201 |
| commercial IGRA blood | 0.663655 |
| tuberculin units/0.1 mL | 0.686625 |
| current shortage | 0.461817 |
| skin test solutions | 0.504545 |
| public health | 0.67809 |
| TB infection | 0.523132 |
| routine serial testing | 0.494493 |
| IGRA blood test | 0.949679 |
| ) disease. | 0.621818 |
| Sanofi Pasteur Limited | 0.530505 |
| TB cases | 0.525471 |
| local TB epidemiology | 0.585255 |
| relative TB risks | 0.583039 |
| tuberculin skin test | 0.667947 |
| specific laboratory services | 0.487973 |
| risk-stratified cut-off measurements | 0.484053 |
| recurrent shortage | 0.468012 |
| TB diagnosis | 0.526695 |
| multiple dose vials | 0.681775 |
|
CLICK HERE |
| 9773 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Patient Satisfaction and Perceived Success with a Telephonic Health Coaching Program: The Natural Experiments for Translation in Diabetes (NEXT-D) Study, Northern California, 2011 - CDC |
Health coaching can improve lifestyle behaviors known to prevent or manage chronic conditions such as diabetes. However, little is known about the patient experience with telephonic coaching programs in real-world care settings. |
| wellness coaching session | 0.51734 |
| Voluntary telephonic health | 0.385861 |
| health coaching programs | 0.434297 |
| health care delivery | 0.506067 |
| Permanente Northern California | 0.479388 |
| patient characteristics | 0.401911 |
| health coaching | 0.752643 |
| telephonic coaching programs | 0.435594 |
| PAM-6 scores | 0.389884 |
| coaching programs | 0.45266 |
| patients | 0.517983 |
| weight-related topics | 0.389601 |
| healthful eating | 0.433808 |
| voluntary health coaching | 0.394928 |
| Kaiser Permanente Wellness | 0.393307 |
| respondents | 0.397043 |
| Kaiser Permanente resources | 0.391444 |
| success | 0.400869 |
| survey | 0.457917 |
| Introduction
Health coaching | 0.419997 |
| Wellness Coaching help | 0.421206 |
| coaching sessions | 0.441286 |
| wellness coaching | 0.914016 |
| population-based telephonic coaching | 0.385667 |
| Kaiser Permanente Northern | 0.44782 |
|
| patient activation | 0.5959 |
| highest activation level | 0.404899 |
| wellness coaching participation | 0.407162 |
| survey response rate | 0.395927 |
| patient activation measure | 0.434241 |
| telephonic health coaching | 0.525849 |
| Kaiser Permanente | 0.509133 |
| PAM-6 activation level | 0.410664 |
| weight-related goal | 0.389282 |
| telephonic Wellness Coaching | 0.440175 |
| large integrated health | 0.417962 |
| healthy weight | 0.391796 |
| satisfaction | 0.437283 |
| health coaching program | 0.482509 |
| wellness coaches | 0.430406 |
| physical activity | 0.468533 |
| lowest activation level | 0.405922 |
| patient satisfaction | 0.41553 |
| activation level | 0.445663 |
| multifaceted wellness program | 0.387016 |
| voluntary telephonic coaching | 0.406879 |
| telephonic coaching program | 0.442029 |
| wellness coaching sessions | 0.428569 |
| health plan | 0.386044 |
|
CLICK HERE |
| 11484 |
Centers for Disease Control and Prevention |
Html |
en |
ELISA Software for Bioassays | Manual | Plot Standard Curves |
Module 5 of the ELISA for Windows user's manual: Plot Standard Curves. |
| Windows interface | 0.301496 |
| available option | 0.297781 |
| plate number field | 0.373535 |
| standards data file | 0.844133 |
| user intervention | 0.377534 |
| screen | 0.313474 |
| fully annotated plot | 0.413165 |
| replicate optical densities | 0.403256 |
| appropriate text box | 0.374963 |
| dialog window | 0.39988 |
| logistic-log function | 0.303995 |
| entire file | 0.467674 |
| file | 0.857008 |
| parameter estimation | 0.538435 |
| standard curve plots | 0.577565 |
| file names | 0.3262 |
| file list box | 0.403457 |
| robust fit | 0.390791 |
| fitting techniques | 0.3153 |
| different file | 0.325086 |
| standard curve | 0.800664 |
| stable set | 0.30424 |
| standards data | 0.849199 |
| parameter estimates | 0.326843 |
|
| plates | 0.318057 |
| point cubic spline | 0.457409 |
| printer | 0.404824 |
| module | 0.403208 |
| coefficient data file | 0.464355 |
| standard curve line | 0.416118 |
| file name box | 0.322611 |
| screen image | 0.294679 |
| particular plate | 0.29552 |
| coefficient file | 0.458811 |
| data file selection | 0.412504 |
| fitted standard curve | 0.433749 |
| repetitive entry | 0.302906 |
| spline fit | 0.91819 |
| logistic-log parameters | 0.298122 |
| standards series | 0.297833 |
| nonparametric fit | 0.392766 |
| single plot | 0.304517 |
| unweighted least squares | 0.407969 |
| additional option | 0.318753 |
| user | 0.554484 |
| median value | 0.311622 |
| module forms | 0.349799 |
|
CLICK HERE |
| 11508 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | DBD News Bulletin Fall 2013 | Vaccine News, Awards |
Division of Bacterial Diseases Bulletin Fall |
| International Program category | 0.751135 |
| CDC Director | 0.717967 |
| state school vaccination | 0.804222 |
| academic microbiological institutions | 0.736986 |
| Reduced Diphtheria Toxoid | 0.754004 |
| Acellular Pertussis | 0.767332 |
| Vaccine Preventable Diseases | 0.804951 |
| Sabin Vaccine Institute | 0.789819 |
| ATSDR Civil Service | 0.752138 |
| laboratory research professionals | 0.751162 |
| vaccination coverage | 0.724264 |
| pertussis serology training | 0.841252 |
| IDWeek Program Committee | 0.771689 |
| high risk infants | 0.767237 |
| American Society | 0.747708 |
| Pertussis Team | 0.772781 |
| pertussis resurgence | 0.766998 |
| related fellowship programs | 0.743117 |
| school vaccination requirements | 0.932593 |
| Investigational New Drug | 0.75621 |
| global health studies | 0.773961 |
| meningococcal disease | 0.898054 |
| public health story | 0.782178 |
| infant meningococcal vaccine | 0.900327 |
| local health authorities | 0.7859 |
|
| American Health Organization | 0.780044 |
| meningococcal vaccine | 0.966297 |
| MCV4 vaccination | 0.737352 |
| United States | 0.829062 |
| Action Photo Contest | 0.748894 |
| malaria diagnostics development | 0.731658 |
| Princeton University | 0.938899 |
| pediatric infectious diseases | 0.73643 |
| Dr. Tom Frieden | 0.75225 |
| public health | 0.818866 |
| nonresidential middle schools | 0.907102 |
| Program Committee Choice | 0.758559 |
| New Jersey Department | 0.75498 |
| research training programs | 0.75263 |
| interdisciplinary D.H.Sc. program | 0.748194 |
| Medical Education-accredited programs | 0.743582 |
| outstanding scientific research | 0.748602 |
| Quality Management principles | 0.740555 |
| Princeton University officials | 0.781778 |
| Nova Southeastern University | 0.75052 |
| annual Public Health | 0.783284 |
| best accepted abstracts | 0.747041 |
| CDC Pertussis | 0.79473 |
| Vaccine Effectiveness | 0.722291 |
|
CLICK HERE |
| 11881 |
Centers for Disease Control and Prevention |
Html |
en |
Control of Ebola Virus Disease - Firestone District,Liberia, 2014 |
On October 21, 2014, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr). |
| Ebola exposure risk | 0.428079 |
| Ebola case definition | 0.456556 |
| Ebola education | 0.416239 |
| Ebola treatment unit | 0.457287 |
| Firestone Natural Rubber | 0.389256 |
| national Ebola case | 0.538974 |
| Ebola clusters | 0.416361 |
| Firestone Liberia | 0.434807 |
| high-risk exposures | 0.381648 |
| Ebola outbreak response | 0.444273 |
| Firestone plantation area | 0.42275 |
| Ebola case | 0.570556 |
| Ebola outbreak | 0.512647 |
| Firestone response | 0.344291 |
| Ebola case definitions | 0.467028 |
| Firestone employee | 0.369501 |
| intense Ebola transmission | 0.480608 |
| Ebola transmission | 0.50373 |
| standard Ebola | 0.474522 |
| Fifty-three Ebola cases | 0.454611 |
| Firestone ETU | 0.347943 |
| Disease — Firestone | 0.370637 |
| ebola survivors | 0.456389 |
| health care | 0.360614 |
|
| Ebola outbreak control | 0.439714 |
| Firestone communities | 0.359362 |
| Firestone District | 0.436595 |
| Ebola case deaths | 0.446852 |
| Firestone plantation | 0.481399 |
| Firestone staff members | 0.371728 |
| ebola virus disease | 0.511075 |
| Firestone HCWs | 0.356222 |
| Ebola response | 0.453109 |
| ebola cases | 0.72775 |
| Ebola patient | 0.500803 |
| Firestone facilities averages | 0.378637 |
| Firestone | 0.696786 |
| initial Ebola case | 0.461654 |
| Ebola signs | 0.43563 |
| Ebola control guidelines | 0.43099 |
| Firestone Tire | 0.365343 |
| Ebola infection control | 0.485646 |
| Firestone rubber tree | 0.392371 |
| Ebola patients | 0.655323 |
| Firestone hospital | 0.345434 |
| Ebola | 0.911553 |
| subsequent Ebola cases | 0.459348 |
|
CLICK HERE |
| 13559 |
Centers for Disease Control and Prevention |
Html |
null |
Effect of Family Income on the Relationship Between Parental Education and Sealant Prevalence, National Health and Nutrition Examination Survey, 2005–2010 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
|
|
CLICK HERE |
| 15863 |
Centers for Disease Control and Prevention |
Html |
en |
Physical Activity, Screen-Based Sedentary Behavior, andSleep Duration in Adolescents: Youth Risk Behavior Survey,2011-2013 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| high PA/low SB | 0.384346 |
| screen-based sedentary behavior | 0.299754 |
| concurrent associations | 0.239267 |
| screen-based SB | 0.912917 |
| high PA/high SB | 0.421672 |
| screen-based SB questions | 0.280914 |
| latent subgroups | 0.455036 |
| latent class analysis | 0.371162 |
| SB interactively influence | 0.201406 |
|
| PA/low SB group | 0.215163 |
| physical activity | 0.332547 |
| PA/low SB subgroup | 0.308998 |
| sufficient sleep | 0.734461 |
| low PA/low SB | 0.421025 |
| sleep duration | 0.269249 |
| PA/high SB subgroup | 0.392774 |
| low levels | 0.218216 |
| screen-based SB items | 0.396581 |
|
CLICK HERE |
| 16002 |
Centers for Disease Control and Prevention |
Html |
null |
Influenza Vaccines and Use of Influenza Antiviral Medications |
Influenza Vaccines and Use of Influenza Antiviral Medications - CDC |
|
|
CLICK HERE |
| 16246 |
Centers for Disease Control and Prevention |
Html |
en |
FastStats - Reproductive Health |
null |
| Sexual Activity | 0.66436 |
| Key Statistics | 0.657272 |
| United States | 0.676825 |
| Percent | 0.599186 |
| sexual intercourse | 0.742344 |
| menstrual period | 0.709287 |
| PID | 0.481303 |
| pelvic inflammatory disease | 0.928581 |
|
| Males | 0.489762 |
| Source | 0.488637 |
| never-married teens | 0.725524 |
| KB | 0.485912 |
| Contraceptive | 0.491745 |
| Teenagers | 0.472153 |
| National Survey | 0.655824 |
| Females | 0.486643 |
|
CLICK HERE |